Biopharmaceutical Industry in India: Market Research Reports, Statistics and Analysis

Biocon Ltd. - Company Report For Year 2013

Biocon Ltd. - Company Report For Year 2012

... Insugen and glargine, basalog coupled with a state of the art insulin pen device, insupen and india S first indigenously produced monoclonal antibody bio ...

Biopharmaceutical In India And The United States : Industry Overv ...

... Such as microbial fermentation or mammalian cell culture. Ge plants, acting as bioreactors, can efficiently produce recombinant proteins in larger quantities than those produced using mammalian cell systems (3 ...

Biosimilar In India And China : Innovation And Technology Trends

Biopharmaceutical Industry (biopharmaceutical, Growth Hormone) I ...

... Such as rhuman growth hormone, rhuman insulin and gcsf. ______________________________________________________________________ Scigen limited arbn 101 318 852 suite 1, 13b narabang way, belrose, nsw 2085 ...

Biopharmaceutical Business (biopharmaceutical, Growth Hormone, Bi ...

... Of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights to manufacture, distribute ...

Biosimilar In India : Innovation And Technology Trends (biosimila ...

... Means more competition more competition means lesser price to patients lesser price is sigh-of-relief for patients benefit of biosimilar evolution in india product pre-1995 current hepatitis b ...

The Future Of The Indian Biopharmaceutical

... As the patents for biologics move closer to their expiration dates and the challenging economic situation across the globe a decrease in healthcare expenditures, biosimilars emerge as the cost ...

The Indian Enzyme Industry Brief (enzyme, Protein)

... Accounts for 10% of the global scenario [29]. The demand of diagnostic and therapeutic enzymes is expected to increase owing to improvement in medical care facilities in developing countries and global ...